Walleye Capital
SLDB icon

Walleye Capital’s Solid Biosciences SLDB Stock Holding History

Walleye Capital’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-55,229
Closed -$204K – 4993
2025
Q1 		$204K Sell
55,229
-103,602
-65% -$444K ﹤0.01% 3245
2024
Q4 		$635K Sell
158,831
-233,270
-59% -$1.28M ﹤0.01% 2789
2024
Q3 		$2.73M Sell
392,101
-19,862
-5% -$161K 0.01% 1666
2024
Q2 		$2.34M Sell
411,963
-164,304
-29% -$1.47M ﹤0.01% 1958
2024
Q1 		$7.68M Buy
576,267
+451,707
+363% +$4.23M 0.01% 1005
2023
Q4 		$765K Buy
124,560
+33,451
+37% +$107K ﹤0.01% 2605
2023
Q3 		$230K Sell
91,109
-1,994
-2% -$7.73K ﹤0.01% 3445
2023
Q2 		$488K Buy
+93,103
New +$524K ﹤0.01% 2466
2020
Q3 		– Sell
-1,615
Closed -$71K – 956
2020
Q2 		$71K Sell
1,615
-1,094
-40% -$45.4K 0.02% 527
2020
Q1 		$97K Sell
2,709
-891
-25% -$44.1K 0.02% 597
2019
Q4 		$240K Buy
+3,600
New +$397K 0.02% 1029
2019
Q3 		– Sell
-2,436
Closed -$210K – 2240
2019
Q2 		$210K Buy
+2,436
New +$266K 0.02% 937

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Walleye Capital's SLDB Position: Q2 2025 in Review

Walleye Capital sold out of Solid Biosciences (SLDB) in Q2 2025, closing a stake of 55,229 shares — an estimated $204K sold.

Walleye Capital first reported a position in SLDB in Q2 2019 and held it in 12 quarters. The position peaked at $7.68M in Q1 2024. 114 funds tracked by Wall St. Rank hold SLDB as of Q2 2025.

  • Walleye Capital reported no remaining Solid Biosciences position as of Q2 2025 after selling out during the quarter.
  • Walleye Capital sold 55,229 Solid Biosciences shares in Q2 2025, an estimated $204K.
  • Walleye Capital first reported a position in Solid Biosciences in Q2 2019 and held it in 12 quarters.
  • Walleye Capital's Solid Biosciences position peaked at $7.68M in Q1 2024.
  • 114 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2025.

Based on Walleye Capital's 13F filing for Q2 2025, filed 13 Aug 2025.